Online Supplemental File
Complete List of References to:
Aging-related Genes in Mesenchymal Stem Cells: A Mini-Review
Kyung-Rok Yu1,2 Kyung-Sun Kang1,2
1
Kirkwood TB: Understanding the odd science of aging. Cell 2005;120:437-447.
2
Hayflick L: How and why we age, ed 1st. New York, Ballantine Books, 1994.
3
Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T,
DePinho RA, Sharpless NE, Scadden DT: Stem-cell ageing modified by the cyclin-dependent
kinase inhibitor p16ink4a. Nature 2006;443:421-426.
4
Chamberlain G, Fox J, Ashton B, Middleton J: Concise review: Mesenchymal stem
cells: Their phenotype, differentiation capacity, immunological features, and potential for
homing. Stem Cells 2007;25:2739-2749.
5
Chao YH, Wu HP, Chan CK, Tsai C, Peng CT, Wu KH: Umbilical cord-derived
mesenchymal stem cells for hematopoietic stem cell transplantation. J Biomed Biotechnol
2012;2012:759503.
6
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC,
Deans RJ, Krause DS, Keating A: Clarification of the nomenclature for msc: The international
society for cellular therapy position statement. Cytotherapy 2005;7:393-395.
7
Kode JA, Mukherjee S, Joglekar MV, Hardikar AA: Mesenchymal stem cells:
Immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy
2009;11:377-391.
8
Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE:
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate
donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114-2120.
9
Schu S, Nosov M, O'Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O'Brien T, Ritter
T: Immunogenicity of allogeneic mesenchymal stem cells. Journal of cellular and molecular
medicine 2012;16:2094-2103.
10
El Haddad N, Heathcote D, Moore R, Yang S, Azzi J, Mfarrej B, Atkinson M, Sayegh
MH, Lee JS, Ashton-Rickardt PG, Abdi R: Mesenchymal stem cells express serine protease
inhibitor to evade the host immune response. Blood 2011;117:1176-1183.
11
Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, Quarto R: Replicative aging
and gene expression in long-term cultures of human bone marrow stromal cells. Tissue
engineering 2002;8:901-910.
12
Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J,
Pfister S, Eckstein V, Ho AD: Replicative senescence of mesenchymal stem cells: A
continuous and organized process. PloS one 2008;3:e2213.
13
Muraglia A, Cancedda R, Quarto R: Clonal mesenchymal progenitors from human
bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113 ( Pt
7):1161-1166.
14
Sperka T, Wang J, Rudolph KL: DNA damage checkpoints in stem cells, ageing and
cancer. Nat Rev Mol Cell Biol 2012;13:579-590.
15
Sengupta N, Seto E: Regulation of histone deacetylase activities. J Cell Biochem
2004;93:57-67.
16
Karantzali E, Schulz H, Hummel O, Hubner N, Hatzopoulos A, Kretsovali A: Histone
deacetylase inhibition accelerates the early events of stem cell differentiation: Transcriptomic
and epigenetic analysis. Genome Biol 2008;9:R65.
17
Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS,
Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, Duan Z, Blau CA:
Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in
embryonic stem cells. Cell stem cell 2009;4:359-369.
18
Li Z, Liu C, Xie Z, Song P, Zhao RC, Guo L, Liu Z, Wu Y: Epigenetic dysregulation in
mesenchymal stem cell aging and spontaneous differentiation. PloS one 2011;6:e20526.
19
Lee S, Park JR, Seo MS, Roh KH, Park SB, Hwang JW, Sun B, Seo K, Lee YS, Kang
SK, Jung JW, Kang KS: Histone deacetylase inhibitors decrease proliferation potential and
multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif
2009;42:711-720.
20
Jung JW, Lee S, Seo MS, Park SB, Kurtz A, Kang SK, Kang KS: Histone deacetylase
controls adult stem cell aging by balancing the expression of polycomb genes and jumonji
domain containing 3. Cell Mol Life Sci 2010;67:1165-1176.
21
Lee S, Jung JW, Park SB, Roh K, Lee SY, Kim JH, Kang SK, Kang KS: Histone
deacetylase regulates high mobility group a2-targeting micrornas in human cord bloodderived multipotent stem cell aging. Cell Mol Life Sci 2011;68:325-336.
22
Jaenisch R, Bird A: Epigenetic regulation of gene expression: How the genome
integrates intrinsic and environmental signals. Nature genetics 2003;33 Suppl:245-254.
23
Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W: DNA methylation
pattern changes upon long-term culture and aging of human mesenchymal stromal cells.
Aging cell 2010;9:54-63.
24
Cervoni N, Szyf M: Demethylase activity is directed by histone acetylation. J Biol
Chem 2001;276:40778-40787.
25
Jin B, Yao B, Li JL, Fields CR, Delmas AL, Liu C, Robertson KD: Dnmt1 and dnmt3b
modulate distinct polycomb-mediated histone modifications in colon cancer. Cancer Res
2009;69:7412-7421.
26
So AY, Jung JW, Lee S, Kim HS, Kang KS: DNA methyltransferase controls stem cell
aging by regulating bmi1 and ezh2 through micrornas. PloS one 2011;6:e19503.
27
Zhang W, Ji W, Yang J, Yang L, Chen W, Zhuang Z: Comparison of global DNA
methylation profiles in replicative versus premature senescence. Life sciences 2008;83:475480.
28
Ivanchuk SM, Mondal S, Dirks PB, Rutka JT: The ink4a/arf locus: Role in cell cycle
control and apoptosis and implications for glioma growth. J Neurooncol 2001;51:219-229.
29
Rayess H, Wang MB, Srivatsan ES: Cellular senescence and tumor suppressor gene
p16. Int J Cancer 2012;130:1715-1725.
30
Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ: Bmi-1
dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature
2003;425:962-967.
31
Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M, Kohno Y, Ito K,
Fujibayashi S, Neo M, Nakayama T, Nakamura T, Toguchida J: Expression of the p16ink4a
gene is associated closely with senescence of human mesenchymal stem cells and is
potentially silenced by DNA methylation during in vitro expansion. Stem Cells 2007;25:23712382.
32
Zheng Y, He L, Wan Y, Song J: H3k9me-enhanced DNA hypermethylation of the
p16(ink4a) gene: An epigenetic signature for spontaneous transformation of rat mesenchymal
stem cells. Stem Cells Dev 2013;22:256-267.
33
Jin Y, Kato T, Furu M, Nasu A, Kajita Y, Mitsui H, Ueda M, Aoyama T, Nakayama T,
Nakamura T, Toguchida J: Mesenchymal stem cells cultured under hypoxia escape from
senescence via down-regulation of p16 and extracellular signal regulated kinase. Biochem
Biophys Res Commun 2010;391:1471-1476.
34
Gu Z, Cao X, Jiang J, Li L, Da Z, Liu H, Cheng C: Upregulation of p16ink4a promotes
cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus
erythematosus patients. Cell Signal 2012;24:2307-2314.
35
Grosschedl R, Giese K, Pagel J: Hmg domain proteins: Architectural elements in the
assembly of nucleoprotein structures. Trends Genet 1994;10:94-100.
36
Zhou X, Benson KF, Ashar HR, Chada K: Mutation responsible for the mouse pygmy
phenotype in the developmentally regulated factor hmgi-c. Nature 1995;376:771-774.
37
Yu KR, Park SB, Jung JW, Seo MS, Hong IS, Kim HS, Seo Y, Kang TW, Lee JY,
Kurtz A, Kang KS: Hmga2 regulates the in vitro aging and proliferation of human umbilical
cord blood-derived stromal cells through the mtor/p70s6k signaling pathway. Stem Cell Res
2012;10:156-165.
38
Pfannkuche K, Summer H, Li O, Hescheler J, Droge P: The high mobility group
protein hmga2: A co-regulator of chromatin structure and pluripotency in stem cells? Stem
Cell Rev 2009;5:224-230.
39
Nishino J, Kim I, Chada K, Morrison SJ: Hmga2 promotes neural stem cell selfrenewal in young but not old mice by reducing p16ink4a and p19arf expression. Cell
2008;135:227-239.
40
Tzatsos A, Bardeesy N: Ink4a/arf regulation by let-7b and hmga2: A genetic pathway
governing stem cell aging. Cell stem cell 2008;3:469-470.
41
Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, Molinolo AA, Mitchell
JB, Gutkind JS: Mtor inhibition prevents epithelial stem cell senescence and protects from
radiation-induced mucositis. Cell stem cell 2012;11:401-414.
42
Hutchison CJ, Worman HJ: A-type lamins: Guardians of the soma? Nat Cell Biol
2004;6:1062-1067.
43
Haithcock E, Dayani Y, Neufeld E, Zahand AJ, Feinstein N, Mattout A, Gruenbaum Y,
Liu J: Age-related changes of nuclear architecture in caenorhabditis elegans. Proc Natl Acad
Sci U S A 2005;102:16690-16695.
44
Melcer S, Gruenbaum Y, Krohne G: Invertebrate lamins. Exp Cell Res
2007;313:2157-2166.
45
Mounkes L, Kozlov S, Burke B, Stewart CL: The laminopathies: Nuclear structure
meets disease. Curr Opin Genet Dev 2003;13:223-230.
46
Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR,
Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M,
Glover TW, Collins FS: Recurrent de novo point mutations in lamin a cause hutchinson-gilford
progeria syndrome. Nature 2003;423:293-298.
47
Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY,
Chen DJ, Pei D, Pendas AM, Cadinanos J, Lopez-Otin C, Tse HF, Hutchison C, Chen J, Cao
Y, Cheah KS, Tryggvason K, Zhou Z: Genomic instability in laminopathy-based premature
aging. Nature medicine 2005;11:780-785.
48
McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K:
The mutant form of lamin a that causes hutchinson-gilford progeria is a biomarker of cellular
aging in human skin. PloS one 2007;2:e1269.
49
Cao K, Blair CD, Faddah DA, Kieckhaefer JE, Olive M, Erdos MR, Nabel EG, Collins
FS: Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal
human fibroblasts. J Clin Invest 2011;121:2833-2844.
50
Rodriguez S, Coppede F, Sagelius H, Eriksson M: Increased expression of the
hutchinson-gilford progeria syndrome truncated lamin a transcript during cell aging. Eur J
Hum Genet 2009;17:928-937.
51
Rosengardten Y, McKenna T, Grochova D, Eriksson M: Stem cell depletion in
hutchinson-gilford progeria syndrome. Aging cell 2011;10:1011-1020.
52
Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, Mutalif RA, Navasankari R, Zhang Y,
Tse HF, Stewart CL, Colman A: A human ipsc model of hutchinson gilford progeria reveals
vascular smooth muscle and mesenchymal stem cell defects. Cell stem cell 2011;8:31-45.
53
Scaffidi P, Misteli T: Lamin a-dependent misregulation of adult stem cells associated
with accelerated ageing. Nat Cell Biol 2008;10:452-459.
54
Corrigan DP, Kuszczak D, Rusinol AE, Thewke DP, Hrycyna CA, Michaelis S,
Sinensky MS: Prelamin a endoproteolytic processing in vitro by recombinant zmpste24.
Biochem J 2005;387:129-138.
55
Ukekawa R, Miki K, Fujii M, Hirano H, Ayusawa D: Accumulation of multiple forms of
lamin a with down-regulation of face-1 suppresses growth in senescent human cells. Genes
Cells 2007;12:397-406.
56
Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, Figg N, Shroff R, Skepper J,
Shanahan CM: Prelamin a acts to accelerate smooth muscle cell senescence and is a novel
biomarker of human vascular aging. Circulation 2010;121:2200-2210.
57
Maraldi NM, Capanni C, Cenni V, Fini M, Lattanzi G: Laminopathies and laminassociated signaling pathways. J Cell Biochem 2011;112:979-992.